The gut microbiome — the trillions of microbes living mostly in the large intestine — maintains the barrier between the gut contents and the bloodstream, produces compounds that regulate inflammation and immunity, and communicates with the brain through multiple channels. With age, the microbiome typically loses diversity and shifts in ways that contribute to chronic inflammation, frailty, and cognitive decline. Diet is the most reliable lever for influencing it, with fibre and fermented foods doing most of the heavy lifting. Specific supplements, personalised tests, and the popular ‘leaky gut’ framing have outrun what the evidence currently supports.
The human gut contains around 30 to 40 trillion microorganisms — bacteria, archaea, fungi, and viruses — with most concentrated in the large intestine. Their collective genes outnumber human genes by roughly a hundred to one. These microbes are not passengers. They break down fibres and complex carbohydrates that human enzymes cannot digest, produce vitamins and short-chain fatty acids, train the immune system, and contribute to the physical barrier between the gut and the bloodstream.
The specific microbes vary substantially between people. Identical twins share only about 35 to 40 per cent of their gut microbial species. Diet, geography, medication history, and early-life factors — birth mode, breastfeeding, childhood antibiotic exposure — all leave lasting signatures. This variability is part of why a recent international consensus paper in Gut concluded that there is still no agreed definition of what a healthy gut microbiome looks like. There are patterns associated with health and patterns associated with disease, but the mapping is probabilistic rather than precise.
The gut influences the rest of the body through four main routes.
1. The intestinal barrier
A single layer of cells, reinforced by a mucus layer and the microbes living within it, separates the gut contents from the bloodstream. When this barrier works well, it is selectively permeable — nutrients pass through, pathogens and inflammatory molecules do not. When it is compromised, pro-inflammatory bacterial components can leak into circulation and drive systemic low-grade inflammation. Intestinal barrier dysfunction is now understood as one of the evolutionarily conserved hallmarks of ageing — a pattern observed across species from fruit flies to humans.
2. Short-chain fatty acids
When gut microbes ferment dietary fibre, they produce short-chain fatty acids — compounds including butyrate, propionate, and acetate. These are the primary fuel for the cells lining the colon, but their effects are systemic. They strengthen the gut barrier, regulate immune function, influence appetite hormones, and appear to reduce inflammation throughout the body. This is the main mechanism by which a fibre-rich diet protects against chronic disease. The evidence supporting it is some of the strongest in the field.
3. The immune system
Roughly seventy per cent of the body’s immune cells reside in or near the gut, and they are in constant conversation with the resident microbes. The microbiome trains the immune system in early life and continues to modulate its activity throughout adulthood. Gut microbial composition influences how the immune system responds to infection, vaccination, and the chronic low-grade inflammation that accumulates with age.
4. The gut-brain axis
The gut and the brain communicate through multiple channels: the vagus nerve carrying signals directly to the brainstem, hormones produced by gut endocrine cells, immune signalling, and microbial metabolites that can influence brain function. The enteric nervous system — sometimes called the ‘second brain’ — contains around 500 million neurons, more than the spinal cord. The biology is real and increasingly well-characterised. Where the research is still catching up is in specific clinical claims about how this works in individual people, particularly for mood and mental health.
The gut microbiome is reasonably stable through adulthood and then shifts in older age. Three patterns are consistent across the research. Diversity — the number of species present — tends to decrease. The core bacterial families that dominate healthy adult microbiomes decline in relative abundance. And the immune-regulatory function of the microbiome weakens, contributing to the chronic low-grade inflammation researchers call ‘inflammaging’.
Inflammaging is not a trivial concept. It refers to persistent, low-level, non-infectious inflammation that accumulates with age and appears to be upstream of many age-related diseases — cardiovascular disease, type 2 diabetes, neurodegeneration, and frailty all share inflammation as a common thread. The gut is one of the key sources and modulators of this inflammation, both directly (through barrier integrity) and indirectly (through short-chain fatty acid production and immune regulation). This is the primary mechanism through which gut health connects to longevity outcomes.
At the other end of the spectrum, people who live into their 90s and beyond show distinctive microbiome patterns — enrichment of specific protective organisms including Akkermansia muciniphila and Bifidobacterium, together with higher capacity to produce beneficial metabolites. This pattern has been documented in Italian, Chinese, Japanese, and Sardinian centenarian cohorts, which is about as robust as observational findings in this field get.
What is harder to determine is whether these microbial patterns caused the longevity or resulted from it. Healthy centenarians have been eating well, staying active, and avoiding illness for nine decades — all of which shape the microbiome in exactly these directions. A recent review pointedly titled ‘Disentangling Cause from Consequence’ argues that much of what is published as ‘dysbiosis causes ageing’ may in fact be ‘ageing causes dysbiosis’, with both driven by underlying lifestyle and health factors. Mendelian randomization studies, which use genetic variants to estimate causal effects, have found that the direct impact of specific microbes on human longevity is real but smaller than raw observational associations suggest. Animal studies are more dramatic: in mice bred with accelerated ageing, fecal microbiota transplantation from healthy donors meaningfully extends both healthspan and lifespan, and a single organism — Akkermansia muciniphila — can produce similar effects on its own. These results do not translate straightforwardly to humans, but they demonstrate that the gut microbiome is causally involved in ageing in at least some organisms.
Centenarians have distinctive gut microbiomes. Whether those microbiomes caused their longevity or resulted from it is not yet fully resolved. Our reading of the evidence is that it is probably some of both.
The wellness-supplement version of ‘leaky gut syndrome’ is something different. It typically involves claiming that a wide range of vague symptoms — fatigue, brain fog, joint pain, skin problems, mood changes — are caused by increased intestinal permeability, that it can be diagnosed through specific tests, and that it can be treated through specific supplements or protocols sold by the same practitioners. There is no peer-reviewed consensus that this syndrome exists as described, no validated diagnostic test for it in routine clinical practice, and no evidence-backed protocol for treating it.
The honest position is that intestinal permeability as a biological phenomenon is real, and probably contributes to age-related chronic disease. The commercial ‘leaky gut syndrome’ framing is not what the peer-reviewed evidence supports. Forever Well uses the research concept and declines to use the commercial one.
The gut and brain communicate constantly through the vagus nerve, hormones, immune signals, and microbial metabolites. All of this is real and actively researched.
Where wellness content tends to outrun the evidence is in specific clinical claims — that a particular probiotic will treat depression, that the microbiome is ‘the root cause’ of anxiety, that gut-based interventions can reliably address mental health in individual members. The broad biological connections between gut and brain are well-established; the specific claim that modifying an individual’s microbiome will produce a particular mental health outcome is not yet supported at the level of clinical evidence. Some small studies are suggestive. None of them are the basis for telling someone that a specific product will meaningfully affect their mood.
The gut-brain axis is one of the most exciting areas of contemporary biomedical research. It is also one of the most prone to being oversold. Take the mechanism seriously, be cautious about specific clinical claims, and watch the research develop.
The strongest dietary intervention trial in this field is the NU-AGE study, published in Gut in 2020. 612 older adults across the UK, France, the Netherlands, Italy, and Poland followed a tailored Mediterranean diet for twelve months. Those who adhered to the diet showed specific microbiome shifts, and those shifts correlated with reduced frailty, better cognitive function, and lower inflammatory markers including C-reactive protein and interleukin-17. The magnitude of the effects was modest — this was a twelve-month intervention in already non-frail adults — but the direction was consistent and biologically plausible.
Several things about this result are worth noting. The intervention was food, not supplements. It took twelve months to produce measurable effects — shorter-horizon ‘gut resets’ are not where the evidence is. The diet was Mediterranean — rich in vegetables, legumes, whole grains, olive oil, nuts, and fish, moderate in dairy, low in red meat and processed foods — not a bespoke gut-specific protocol.
A 2021 Stanford study in Cell found that a ten-week diet high in fermented foods — live-culture yoghurt, kefir, kimchi, sauerkraut, kombucha — significantly increased microbial diversity and reduced nineteen different inflammatory proteins in healthy adults. A high-fibre diet alone, over the same period, did neither. The implication is not that fibre does not matter — it does, through short-chain fatty acid production — but that fermented foods may produce faster and more reliable diversity gains in healthy adults. Combining both appears to be the strongest approach.
The broader pattern across the dietary intervention literature is consistent: fibre quantity and diversity, fermented food intake, polyphenol-rich plant foods, and minimising ultra-processed foods all move the microbiome in protective directions. Physical activity contributes independently. Avoiding unnecessary antibiotics matters. Sleep and stress management matter. None of this is exotic, and that is the point.
The boring recommendations are the ones the evidence actually supports. The exotic-sounding ones — specific probiotic strains, personalised microbiome testing, branded protocols — are mostly running ahead of what the research can justify.
The gut microbiome is a genuine longevity variable. The mechanisms connecting it to systemic health are well-characterised at the biological level, even if the specific clinical implications for individual members remain partly uncertain. The evidence supporting diet-led, consistent, gradual modification is strong. The evidence supporting commercial products, personalised tests, and specific supplements is considerably weaker. Navigating that gap honestly — taking the biology seriously while declining to sell what cannot be defended — is the stance this pillar takes.
